(PharmaNewsWire.Com, June 29, 2017 ) Global In-vitro Fertilization Market is projected to reach USD 3.72 billion by 2021, at a CAGR of 16.4% from 2016 to 2021.In vitro fertilization (IVF) is the joining of a woman's egg and a man's sperm in a laboratory dish. In vitro means outside the body. Fertilization means the sperm has attached to and entered the egg. Normally, an egg and sperm are fertilized inside a woman's body. If the fertilized egg attaches to the lining of the womb and continues to grow, a baby is born about 9 months later. This process is called natural or unassisted conception.
IVF is a form of assisted reproductive technology (ART). This means special medical techniques are used to help a woman become pregnant. It is most often tried when other, less expensive fertility techniques have failed. Women who undergo IVF must take daily shots or pills of the hormone progesterone for 8 to 10 weeks after the embryo transfer. Progesterone is a hormone produced naturally by the ovaries that helps thicken the lining of the womb (uterus). This makes it easier for the embryo to implant. Too little progesterone during the early weeks of pregnancy may lead to miscarriage.
The factors influencing the Global Market for In-vitro Fertilization Market, either positively or negatively are presented in the DROC analysis. Some of the positive things discussed in the section are growing number of delayed pregnancies among women, rising awareness pertaining to infertility consequences, and presence of favorable reimbursement systems. In addition, increasing technological advancements in in-vitro fertilization procedures (embryo scope & capsule in-vitro fertilization), rising medical tourisms across the major countries, growing gynecological disorders & fertility disorders, increasing focus of clinical research institutes towards the innovation of in-vitro fertilization technologies, and occurrence of lifestyle disorders (obesity & smoking that favor infertility) are further propelling the growth of the global in-vitro fertilization market. However, requirement of high capital & time for the running of in-vitro fertilization procedures, difficulties to maintain the in-vitro fertilization procedures, chances of occurrence multiple pregnancies, presence of ethical issues pertaining to selection of gender population, and unawareness of infertility issues in certain under-developed economies are restraining the growth of the global in-vitro fertilization market.
For granular level understanding, the In-vitro Fertilization Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segment.
• By Reagents and Media o Embryo Culture Media o Cryopreservation Media o Sperm Processing Media o Ovum Processing Media
• By Instruments o Imaging Systems o Sperm Separation Systems o Ovum Aspiration Pumps o Incubators o Micromanipulator Systems o Cryosystems o Other Instruments (Gas Analyzers, Laser Systems, Accessories)
• By Technology o Intra-Cytoplasmic Sperm Injection (ICSI) o Pre-Implantation Genetic Diagnosis (PGD) o Frozen Embryo Transfer/Replacement (FET/FER) o Other Technologies
• By End Users o Fertility and Surgical Centers o Hospitals and Research Laboratories o Cryobanks
On the basis of geographical region the global in-vitro fertilization market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Europe commanded the highest share of 37.0% of the global in-vitro fertilization market in 2016, whereas Asia-Pacific is estimated to grow at the highest CAGR during the forecast period 2016-2021.
The key players in global in-vitro fertilization market such as, CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and The Baker Company, Inc. (U.S.).
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
